• Explore /
  • Poster
  • / Results of a randomized, open-label, multicenter trial to assess the safety, dose, and schedule ofRRx-001(001) in reducing incidence, severity and duration of severe oral mucositis (SOM) inpatients receiving concomitant chemoradiation (CRT) for advanced head and neck cancer (HNC).

Results of a randomized, open-label, multicenter trial to assess the safety, dose, and schedule ofRRx-001(001) in reducing incidence, severity and duration of severe oral mucositis (SOM) inpatients receiving concomitant chemoradiation (CRT) for advanced head and neck cancer (HNC).

Abstract Video & Slides Poster

Authors

null

Marcelo Raul Bonomi

James Cancer Hospital Solove Research Institute, The Ohio State University, Columbus, OH

Marcelo Raul Bonomi , David Sher , Dukagjin Blakaj , Rafi Kabarriti , Kyle Colvett , Bryan Oronsky , Stephen T. Sonis , James A. Bianco

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

NCT03515538

Citation

J Clin Oncol 38: 2020 (suppl; abstr 12081)

DOI

10.1200/JCO.2020.38.15_suppl.12081

Abstract #

12081

Poster Bd #

369

Abstract Disclosures

Similar Posters

First Author: Bryan G. Allen

First Author: Tony R. Reid

First Author: Marcelo Raul Bonomi

First Author: Colin D. Weekes